Neurocrine Biosciences, Inc. (NBIX) Analyst Forecast

NASDAQ Currency in USD Disclaimer

Stock Price

$111.65

-$0.51

(-0.45%)

Day's range

$110.99

$112.21

Consensus Rating

Hold

Based on 28 Analyst Ratings
Consensus Price Target

$146.60

31.3% Upside

Recent Analyst Forecasts and Stock Ratings

Date	Brokerage Firm	Analyst Name	Price Target	Price when Posted	Upside/Downside on Report Date
09/13/2024	BMO Capital	Evan David Seigerman	$128.00	$122.29	4.67%
09/09/2024	Barclays	Carter Gould	$160.00	$120.17	33.14%
08/29/2024	RBC Capital	Brian Abrahams	$136.00	$123.76	9.89%
08/28/2024	Piper Sandler	David Amsellem	$159.00	$128.43	23.8%
07/12/2024	Morgan Stanley	Jeffrey Hung	$170.00	$146.50	16.04%
06/06/2024	RBC Capital	Brian Abrahams	$141.00	$133.69	5.47%
05/28/2024	UBS	Ashwani Verma	$193.00	$139.40	38.45%
05/13/2024	Evercore ISI	Cory Kasimov	$175.00	$136.15	28.53%
05/02/2024	Canaccord Genuity	Sumant Kulkarni	$164.00	$143.03	14.66%
05/02/2024	H.C. Wainwright	Andrew Fein	$160.00	$143.03	11.86%
04/23/2024	Wells Fargo	Mohit Bansal	$170.00	$139.35	22%
03/12/2024	Oppenheimer	Jay Olson	$200.00	$137.74	45.2%
11/01/2022	Piper Sandler	David Amsellem	$103.00	$119.36	-13.71%
11/01/2022	Robert W. Baird	Brian Skorney	$150.00	$119.36	25.67%
11/01/2022	H.C. Wainwright	Andrew Fein	$140.00	$119.36	17.29%
11/01/2022	SVB Securities	Marc Goodman	$115.00	$119.36	-3.65%
02/13/2022	H.C. Wainwright	Andrew Fein	$140.00	$86.52	61.81%
02/10/2022	Raymond James	Danielle Brill	$125.00	$85.53	46.15%
02/10/2022	Robert W. Baird	Brian Skorney	$117.00	$85.53	36.79%
02/10/2022	Leerink Partners	Marc Goodman	$100.00	$85.53	16.92%
02/10/2022	Stifel Nicolaus	Paul Matteis	$136.00	$85.53	59.01%
01/25/2022	Bank of America Securities	Tazeen Ahmad	$127.00	$75.51	68.19%
01/19/2022	Barclays	Carter Gould	$100.00	$72.80	37.36%
12/07/2021	Citigroup	Neena Bitritto-Garg	$129.00	$84.26	53.1%
11/01/2021	Cantor Fitzgerald	Charles Duncan	$123.00	$95.58	28.69%
11/01/2021	Evercore ISI	Joshua Schimmer	$130.00	$95.58	36.01%
08/05/2021	Canaccord Genuity	Sumant Kulkarni	$108.00	$89.57	20.58%
08/03/2021	Wedbush	Laura Chico	$112.00	$93.20	20.17%

Neurocrine Biosciences, Inc. Frequently Asked Questions

What analysts cover Neurocrine Biosciences, Inc.?

Neurocrine Biosciences, Inc. has been rated by research analysts at BMO Capital, Barclays, RBC Capital, Piper Sandler, Morgan Stanley, UBS in the past 90 days.

Get The App

Neurocrine Biosciences, Inc. (NBIX) Analyst Forecast

Consensus Rating

Consensus Price Target

Recent Analyst Forecasts and Stock Ratings

Neurocrine Biosciences, Inc. Frequently Asked Questions

What analysts cover Neurocrine Biosciences, Inc.?

Select an alert type

Setup alert

Premium Content

Log In

Email Verification

Welcome to StockNews!

Create Your Account

Email Verification